LUMAXIS
Dead / Abandoned — Abandoned — no statement of use filed (as of 28 Sept 2007)
What this means for you
This application is over — abandoned 28 Sept 2007. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78424664
- Mark type
- Stylized text
- Filed
- 25 May 2004
- Published for opposition
- 05 Jul 2005
- Abandoned
- 28 Sept 2007
- Attorney of record
- Tanya Fickenscher
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations used to increase heart rate and contrast imaging agents.
Owner
- Bristol-Myers Squibb Pharma Company, Princeton, NJ, US
- Bristol-Myers Squibb Pharma Company, Princeton, NJ, US
Prior registrations
Prosecution history
- 13 Dec 2007 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 07 Dec 2007 — ABANDONMENT - NO USE STATEMENT FILED
- 29 Jan 2007 — SOU EXTENSION 3 GRANTED
- 29 Jan 2007 — SOU EXTENSION 3 FILED
- 29 Jan 2007 — SOU TEAS EXTENSION RECEIVED
- 15 Aug 2006 — SOU EXTENSION 2 GRANTED
- 15 Aug 2006 — SOU EXTENSION 2 FILED
- 15 Aug 2006 — SOU TEAS EXTENSION RECEIVED
- 05 Oct 2005 — SOU EXTENSION 1 GRANTED
- 05 Oct 2005 — SOU EXTENSION 1 FILED
- 05 Oct 2005 — SOU TEAS EXTENSION RECEIVED
- 27 Sept 2005 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 05 Jul 2005 — PUBLISHED FOR OPPOSITION
- 15 Jun 2005 — NOTICE OF PUBLICATION
- 28 Mar 2005 — LAW OFFICE PUBLICATION REVIEW COMPLETED